James T Rague1, Jeremy D Lai2, Peggy Murphy3, Andrea Fawcett3, Ryan Walton1, Ilina Rosoklija1, Diana K Bowen1, Elizabeth B Yerkes1, Earl Y Cheng1, Kavita S Hodgkins4, Jonathan C Routh5, Tamara Isakova6, David I Chu1. 1. Division of Urology, Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, Illinois. 2. Department of Urology, Northwestern University Feinberg School of Medicine, Chicago, Illinois. 3. Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, Illinois. 4. Division of Kidney Disease, Department of Pediatrics, Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, Illinois. 5. Division of Urology, Duke University School of Medicine, Durham, North Carolina. 6. Center for Translational Metabolism and Health, Institute for Public Health and Medicine, and Division of Nephrology and Hypertension, Feinberg School of Medicine at Northwestern University, Chicago, Illinois.
Abstract
PURPOSE: We systematically reviewed the variability in definitions of kidney abnormality (KA) outcomes in individuals with spina bifida (SB). MATERIALS AND METHODS: A systematic scoping review was conducted using MEDLINE, Embase™, Cochrane Library, CINAHL, PsycInfo®, Web of Science™ and ClinicalTrials.gov for articles from time of database inception to September 2020. No language or patient age restrictions were applied. Primary research articles involving individuals with SB where KA was assessed as an outcome were included. Means of assessing KA and defining KA severity were abstracted. RESULTS: Of 2,034 articles found, 274 were included in the review. Most articles were published after 1990 (63.5%) and included pediatric-only populations (0-18 years; 60.5%). KA outcomes were identified by imaging-based anatomical outcomes (84.7%), serum-based outcomes (44.9%), imaging-based functional outcomes (5.5%), urine-based outcomes (3.3%) and diagnoses of end-stage kidney disease (2.6%) or chronic kidney disease otherwise unspecified (1.8%). Hydronephrosis was the most commonly used specific outcome (64.6%, 177/274) with 19.8% (35/177) of articles defining hydronephrosis severity. Hydronephrosis was used more frequently in articles with pediatric-only populations. Creatinine and cystatin-C were used in 82.1% (101/123) and 17.9% (22/123) of articles reporting serum-based outcomes, respectively, with 32.7% and 50.0% of articles defining estimated glomerular filtration rate (GFR) severity. Serum-based outcomes were more common in articles including adults >18 years. Measured GFR was assessed in 9.9% (27/274) of articles, with 44.4% (12/27) of articles defining GFR severity. CONCLUSIONS: Significant variability exists in how authors define KA with few specifically defining KA severity. Consensus and consistency in defining KA outcomes are needed.
PURPOSE: We systematically reviewed the variability in definitions of kidney abnormality (KA) outcomes in individuals with spina bifida (SB). MATERIALS AND METHODS: A systematic scoping review was conducted using MEDLINE, Embase™, Cochrane Library, CINAHL, PsycInfo®, Web of Science™ and ClinicalTrials.gov for articles from time of database inception to September 2020. No language or patient age restrictions were applied. Primary research articles involving individuals with SB where KA was assessed as an outcome were included. Means of assessing KA and defining KA severity were abstracted. RESULTS: Of 2,034 articles found, 274 were included in the review. Most articles were published after 1990 (63.5%) and included pediatric-only populations (0-18 years; 60.5%). KA outcomes were identified by imaging-based anatomical outcomes (84.7%), serum-based outcomes (44.9%), imaging-based functional outcomes (5.5%), urine-based outcomes (3.3%) and diagnoses of end-stage kidney disease (2.6%) or chronic kidney disease otherwise unspecified (1.8%). Hydronephrosis was the most commonly used specific outcome (64.6%, 177/274) with 19.8% (35/177) of articles defining hydronephrosis severity. Hydronephrosis was used more frequently in articles with pediatric-only populations. Creatinine and cystatin-C were used in 82.1% (101/123) and 17.9% (22/123) of articles reporting serum-based outcomes, respectively, with 32.7% and 50.0% of articles defining estimated glomerular filtration rate (GFR) severity. Serum-based outcomes were more common in articles including adults >18 years. Measured GFR was assessed in 9.9% (27/274) of articles, with 44.4% (12/27) of articles defining GFR severity. CONCLUSIONS: Significant variability exists in how authors define KA with few specifically defining KA severity. Consensus and consistency in defining KA outcomes are needed.
Authors: Mikyong Shin; Lilah M Besser; Csaba Siffel; James E Kucik; Gary M Shaw; Chengxing Lu; Adolfo Correa Journal: Pediatrics Date: 2010-07-12 Impact factor: 7.124
Authors: David I Chu; Lauren C Balmert; Cameron M Arkin; Theresa Meyer; Ilina Rosoklija; Belinda Li; Kavita S Hodgkins; Susan L Furth; Earl Y Cheng; Elizabeth B Yerkes; Tamara Isakova Journal: Neurourol Urodyn Date: 2019-07-08 Impact factor: 2.696
Authors: Stefania Musco; Barbara Padilla-Fernández; Giulio Del Popolo; Matteo Bonifazi; Bertil F M Blok; Jan Groen; Lisette 't Hoen; Jürgen Pannek; Jerome Bonzon; Thomas M Kessler; Marc P Schneider; Tobias Gross; Gilles Karsenty; Véronique Phé; Rizwan Hamid; Hazel Ecclestone; David Castro-Diaz Journal: Neurourol Urodyn Date: 2018-02-02 Impact factor: 2.696
Authors: Jonathan C Routh; Earl Y Cheng; J Christopher Austin; Michelle A Baum; Patricio C Gargollo; Richard W Grady; Adrienne R Herron; Steven S Kim; Shelly J King; Chester J Koh; Pangaja Paramsothy; Lisa Raman; Michael S Schechter; Kathryn A Smith; Stacy T Tanaka; Judy K Thibadeau; William O Walker; M Chad Wallis; John S Wiener; David B Joseph Journal: J Urol Date: 2016-07-27 Impact factor: 7.450
Authors: Julia B Finkelstein; James T Rague; Jeanne Chow; Alyssia Venna; Tanya Logvinenko; Caleb P Nelson; Richard S Lee Journal: Urology Date: 2020-01-28 Impact factor: 2.649